Patent details

EP2579877 Title: MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY

Basic Information

Publication number:
EP2579877
PCT Application Number:
PCT/GB/2011/051074
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117254946
PCT Publication Number:
WO/2011/154737
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY
French Title of Invention:
MORPHOLINOPYRIMIDINES ET LEUR UTILISATION EN THÉRAPIE
German Title of Invention:
MORPHOLINOPYRIMIDINE UND IHRE VERWENDUNG FÜR THERAPEUTISCHE ZWECKE
SPC Number:

Dates

Filing date:
09/06/2011
Grant date:
13/08/2014
EP Publication Date:
13/08/2014
PCT Publication Date:
15/12/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2013
EP B1 Publication Date:
13/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/06/2011
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
18/09/2014
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
FOOTE Kevin, Michael
Address:
United Kingdom (GB)

2

Name:
NISSINK Johannes, Wilhelmus, Maria
Address:
United Kingdom (GB)

3

Name:
TURNER Paul
Address:
United Kingdom (GB)

Priority

Priority Number:
353713 P
Priority Date:
11/06/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/505;

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/05/2025
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages